Andujar, Quiel Timothy C.
HRN: 22-50-89 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/28/2023
CEFTRIAXONE 1G (VIAL)
01/28/2023
02/04/2023
IVT
625 Mg
12 Hrs
T/c Typhoid Fever
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes